Cargando…
Interpreting the Benefit and Risk Data in Between-Drug Comparisons: Illustration of the Challenges Using the Example of Mefenamic Acid versus Ibuprofen
Evidence-based pain therapy should rely on precisely defined and personalized criteria. This includes balancing the benefits and risks not only of single drugs but often requires complex between-drug comparisons. Non-steroidal anti-inflammatory drugs (NSAIDs) have been available for several decades...
Autores principales: | Farkouh, André, Hemetsberger, Margit, Noe, Christian R., Baumgärtel, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609416/ https://www.ncbi.nlm.nih.gov/pubmed/36297674 http://dx.doi.org/10.3390/pharmaceutics14102240 |
Ejemplares similares
-
Sex-Related Differences in Drugs with Anti-Inflammatory Properties
por: Farkouh, André, et al.
Publicado: (2021) -
Differential Sensitivity and Mechanism of Inhibition of COX-2 Oxygenation of Arachidonic Acid and 2-Arachidonoylglycerol by Ibuprofen and Mefenamic Acid
por: Prusakiewicz, Jeffery J., et al.
Publicado: (2009) -
Carboranyl Analogues of Mefenamic Acid and Their Biological
Evaluation
por: Useini, Liridona, et al.
Publicado: (2022) -
Mini-review: medication safety of red yeast rice products
por: Farkouh, André, et al.
Publicado: (2019) -
To Study the Efficacy and Safety of Diosmin with Tranexamic Acid and Mefenamic Acid Versus only Tranexamic Acid and Mefenamic Acid in Medical Management of Abnormal Uterine Bleeding: A Randomized Controlled Trial
por: Sharma, J. B., et al.
Publicado: (2023)